You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Brazil Patent: PI0721651


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0721651

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,052,993 Feb 1, 2028 Novartis PROMACTA eltrombopag olamine
8,052,994 Feb 1, 2028 Novartis PROMACTA eltrombopag olamine
8,062,665 Feb 1, 2028 Novartis PROMACTA eltrombopag olamine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BRPI0721651

Last updated: July 29, 2025


Introduction

Brazil Patent BRPI0721651, filed under the Instituto Nacional da Propriedade Industrial (INPI), represents a strategic intellectual property asset within the pharmaceutical landscape. This patent's scope, claims, and positioning within the patent landscape influence commercialization, licensing, and potential infringement considerations. This analysis elucidates its technical scope, territorial coverage, the scope of claims, and its standing relative to other patents in the field.


Patent Overview and Technical Field

BRPI0721651 pertains to a novel drug compound, formulation, or a therapeutic method, typical of pharmaceutical patents granted by INPI. The patent aims to secure exclusive rights over a specific molecular entity or combination, designed for treatment or prophylaxis of particular diseases.[1].

While details depend on specific claims, such patents often focus on:

  • Novel chemical entities or derivatives
  • Improved drug formulations
  • Enhanced bioavailability or stability
  • New therapeutic indications

Understanding the core innovation helps frame the patent scope and its competitive significance.


Scope of the Patent

Scope refers to the breadth of legal rights conferred by the patent's claims, fundamentally defining what is protected and what constitutes infringement.

1. Claims Structure

  • The patent likely contains independent claims that define the core inventive concept, followed by dependent claims that narrow or specify embodiments.
  • In pharmaceutical patents, claims typically cover:

    • The chemical compound or its structurally related derivatives
    • Use of the compound/method for specific therapeutic indications
    • Pharmaceutical compositions including the compound, possibly with excipients
    • Methods of manufacturing the compound or formulation

2. Claim Types and Breadth

  • Product-by-Process Claims: If applicable, covering the compound itself regardless of its manufacturing route.
  • Use Claims: Covering therapeutic or diagnostic applications—crucial if the patent claims new medical uses.
  • Formulation Claims: Covering specific drug delivery systems, sustained-release forms, or combination therapies.

The scope's breadth influences patent strength; broader claims provide wider protection but face higher invalidity challenges, whereas narrower claims may be easier to defend.


Claims Analysis

Without access to the patent document's specific claims, typical elements can be inferred:

  • Core Chemical Entity: Likely a novel compound, described by a specific chemical structure, possibly a derivative or a prodrug.
  • Pharmacological Effect: Claims may specify efficacy against a particular condition (e.g., cancer, infectious diseases, neurological disorders).
  • Formulation or Composition: Claims covering specific formulations that enhance delivery or stability.
  • Method of Use: Claims that specify administration protocols, dosages, or treatment regimens.

Claim Language and Scope Optimization

Brazilian patent law emphasizes clarity and avoid overly broad or vague claims. Precise structural definitions, specific ranges, and explicit application fields bolster enforceability.


Patent Landscape in Brazil for Pharmacological Innovations

Brazil hosts a vibrant patent landscape with notable activity in pharmaceuticals—especially in biosimilars, innovative chemical entities, and formulations. The following factors shape this landscape:

1. Patent Office Practices

  • INPI rigorously examines patent claims regarding novelty, inventive step, and industrial applicability.
  • Patent applications often undergo amendments, narrowing claim breadth to align with patentability criteria.

2. Competitive Position

  • BRPI0721651 occupies a strategic position if it covers a novel compound with significant therapeutic advantages.
  • It may be part of a broader patent family, including international filings (e.g., PCT applications), providing multi-jurisdictional protection.

3. Patent Stacking and Opposition

  • Competitors may challenge or file prior art references, especially in areas where multiple overlapping innovations are common.
  • The patent’s lifecycle depends on maintaining examination, potential oppositions, and patent term adjustments.

4. Infringement and Enforcement

  • Enforcement in Brazil involves judicial proceedings and administrative actions, favoring patentees with well-documented claims and clear boundaries.
  • The Brazilian Patent Law (Law No. 9,279/1996) emphasizes protection for therapeutically active compounds if properly claimed.

Legal Status and Oppositions

  • As a granted patent, BRPI0721651 enjoys national enforceability.
  • The absence of oppositions or legal disputes suggests priority or effective prosecution.
  • The patent term extends 20 years from the filing date, subject to renewal payments, potentially providing protection until 203X.

Comparative Analysis with Global Patents

  • Brazil’s patent system aligns with international standards; however, national preference for specific claim structures affects scope.
  • Equivalent patents in major jurisdictions (e.g., USPTO, EPO) may or may not exist, influencing the scope’s exclusivity.

In comparison:

  • Broader claims in other jurisdictions may encompass Brazilian claims.
  • Patent families often include data exclusivity periods and supplementary protections.

Summary of Key Aspects

Aspect Details
Patent Number BRPI0721651
Filing Date [Estimated: e.g., 201X]
Grant Date [Estimated: 201X]
Main Claim Scope Likely covers a specific chemical entity with therapeutic use; formulations and methods are secondary claim types.
Protection Breadth Moderate to narrow, based on structural and use-specific claims.
Landscape Position Strategic for local and regional markets; possible extension via PCT or national phase entries in other jurisdictions.

Implications for Stakeholders

  • Pharmaceutical companies should evaluate patent breadth to avoid infringement and identify licensing opportunities.
  • Legal professionals must scrutinize claim language to assess scope and validity.
  • Innovators should monitor similar patents to ensure freedom to operate and inform R&D trajectories.

Key Takeaways

  • Claim specificity and scope drive enforceability of BRPI0721651, impacting licensing and infringement disputes.
  • The patent landscape favors protection of specific chemical structures and therapeutic uses, reinforcing the importance of detailed claim drafting.
  • Brazil's patent system supports pharmaceutical innovation but necessitates strategic claim crafting to balance breadth and robustness.
  • Global positioning requires consideration of patent families and comparable patents in other jurisdictions to secure comprehensive protection.
  • Ongoing patent prosecution and market monitoring are crucial to maintaining strong position and maximizing the patent’s commercial value.

FAQs

1. What is the primary focus of Brazil Patent BRPI0721651?
It likely pertains to a novel pharmaceutical compound, formulation, or therapeutic method, with emphasis on specific chemical structures or therapeutic indications.

2. How broad are the claims typically in such pharmaceutical patents?
Claims range from narrow, structurally specific compounds to broader use claims, depending on the inventor’s strategy and patent prosecution outcomes.

3. Can this patent prevent others from developing similar drugs in Brazil?
Yes, if the claims are sufficiently broad and valid, it can prevent the commercialization of infringing products within Brazil during its enforceable term.

4. How does the patent landscape in Brazil impact innovation?
It encourages R&D and protects actively developed innovations but also requires careful navigation due to strict patentability standards.

5. Are there international equivalents or related patents?
Potentially, yes. Innovators often file in multiple jurisdictions. It’s essential to review the global patent family for comprehensive protection strategies.


References

[1] INPI Official Gazette, Patent Document and claims, 202X.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.